180 related articles for article (PubMed ID: 11974481)
1. [The surgeon as a cost factor. Cost analysis exemplified by surgical treatment of rectal carcinoma].
Meyer T; Merkel S; Pfaffenberger M; Hohenberger W
Chirurg; 2002 Feb; 73(2):167-73. PubMed ID: 11974481
[TBL] [Abstract][Full Text] [Related]
2. [Indicators of quality in surgical treatment of rectal carcinoma].
Junginger T; Kneist W; Sultanov F; Heintz A
Chirurg; 2003 May; 74(5):444-50; discussion 450-1. PubMed ID: 12748793
[TBL] [Abstract][Full Text] [Related]
3. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcome of anastomosis leakage after curative resection for mid and low rectal cancer.
Chang SC; Lin JK; Yang SH; Jiang JK; Chen WC; Lin TC
Hepatogastroenterology; 2003; 50(54):1898-902. PubMed ID: 14696429
[TBL] [Abstract][Full Text] [Related]
5. Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade.
Wheeler JM; Dodds E; Warren BF; Cunningham C; George BD; Jones AC; Mortensen NJ
Dis Colon Rectum; 2004 Dec; 47(12):2025-31. PubMed ID: 15657650
[TBL] [Abstract][Full Text] [Related]
6. Outcome of postoperative treatment for rectal cancer UICC stage II and III in day-to-day clinical practice. Results from a retrospective quality control analysis in six institutions in North Bavaria (Germany).
Wulf J; Krämer K; van Aaken C; Dietzel F; Lucas D; Pfändner K; Schimpke T; Schulze W; Thiel HJ; Ziegler K; Flentje M
Strahlenther Onkol; 2004 Jan; 180(1):5-14. PubMed ID: 14704839
[TBL] [Abstract][Full Text] [Related]
7. Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer.
Das P; Skibber JM; Rodriguez-Bigas MA; Feig BW; Chang GJ; Hoff PM; Eng C; Wolff RA; Janjan NA; Delclos ME; Krishnan S; Levy LB; Ellis LM; Crane CH
Am J Clin Oncol; 2006 Jun; 29(3):219-24. PubMed ID: 16755173
[TBL] [Abstract][Full Text] [Related]
8. [Total mesorectal excison and colonic-J-pouch-anal anastomosis in the therapy of low rectal carcinoma--results in 116 patients].
Ommer A; Girona-Johannkemper M; Jung KP; Berg E
Zentralbl Chir; 2002 Sep; 127(9):775-80. PubMed ID: 12221559
[TBL] [Abstract][Full Text] [Related]
9. Reoperation for intraluminal rectal cancer recurrence.
Rudmik LR; Buie WD; Heine JA
Dis Colon Rectum; 2005 Sep; 48(9):1752-4. PubMed ID: 15991062
[TBL] [Abstract][Full Text] [Related]
10. [After-care of gastrointestinal malignancies--an evaluation of costs and benefits].
Zieren HU; Müller JM
Zentralbl Chir; 1996; 121(3):167-76. PubMed ID: 8867342
[TBL] [Abstract][Full Text] [Related]
11. Randomised clinical trial of adjuvant postoperative RT vs. sequential postoperative RT plus 5-FU and levamisole in patients with stage II-III resectable rectal cancer: a final report.
Cafiero F; Gipponi M; Lionetto R;
J Surg Oncol; 2003 Jul; 83(3):140-6. PubMed ID: 12827681
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of recurrence and prognosis after surgical resection for I stage lower rectal carcinoma].
Zhao DB; Bi JJ; Gao JD; Shao YF; Zhao P
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Mar; 9(2):117-20. PubMed ID: 16555148
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of defunctioning stomas in low anterior resections for rectal cancer: a call for benchmarking.
Koperna T
Arch Surg; 2003 Dec; 138(12):1334-8; discussion 1339. PubMed ID: 14662534
[TBL] [Abstract][Full Text] [Related]
14. Outcome of anterior resection for stage II rectal cancer without radiation: the role of adjuvant chemotherapy.
Law WL; Ho JW; Chan R; Au G; Chu KW
Dis Colon Rectum; 2005 Feb; 48(2):218-26. PubMed ID: 15711860
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for anastomotic leakage after anterior resection of the rectum.
Matthiessen P; Hallböök O; Andersson M; Rutegård J; Sjödahl R
Colorectal Dis; 2004 Nov; 6(6):462-9. PubMed ID: 15521937
[TBL] [Abstract][Full Text] [Related]
16. Patient profile and treatment outcome of rectal cancer patients treated with multimodality therapy at a regional cancer center.
Deo S; Kumar S; Shukla NK; Kar M; Mohanti BK; Sharma A; Raina V; Rath GK
Indian J Cancer; 2004; 41(3):120-4. PubMed ID: 15472410
[TBL] [Abstract][Full Text] [Related]
17. Analysis of surgical salvage after failure of primary therapy in rectal cancer: results from Intergroup Study 0114.
Tepper JE; O'Connell M; Hollis D; Niedzwiecki D; Cooke E; Mayer RJ;
J Clin Oncol; 2003 Oct; 21(19):3623-8. PubMed ID: 14512393
[TBL] [Abstract][Full Text] [Related]
18. Prognostic and predictive factors after surgical treatment for locally recurrent rectal cancer: a single institute experience.
Asoglu O; Karanlik H; Muslumanoglu M; Igci A; Emek E; Ozmen V; Kecer M; Parlak M; Kapran Y
Eur J Surg Oncol; 2007 Dec; 33(10):1199-206. PubMed ID: 17400423
[TBL] [Abstract][Full Text] [Related]
19. [Total excision of the mesorectum in cancer of the lower and middle rectum. Oncological and functional results].
Kneist W; Heintz A; Wolf HK; Junginger T
Chirurg; 2003 Feb; 74(2):125-31. PubMed ID: 12599030
[TBL] [Abstract][Full Text] [Related]
20. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients.
Bonnen M; Crane C; Vauthey JN; Skibber J; Delclos ME; Rodriguez-Bigas M; Hoff PM; Lin E; Eng C; Wong A; Janjan NA; Feig BW
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1098-105. PubMed ID: 15519780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
